A carregar...
Sulforaphane attenuates EGFR signaling in NSCLC cells
BACKGROUND: EGFR, a receptor tyrosine kinase (RTK), is frequently overexpressed and mutated in non-small cell lung cancer (NSCLC). Tyrosine kinase inhibitors (TKIs) have been widely used in the treatment of many cancers, including NSCLC. However, intrinsic and acquired resistance to TKI remains a co...
Na minha lista:
| Publicado no: | J Biomed Sci |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4451877/ https://ncbi.nlm.nih.gov/pubmed/26036303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-015-0139-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|